loading
Apogee Therapeutics Inc stock is traded at $55.15, with a volume of 1.04M. It is up +3.28% in the last 24 hours and up +46.56% over the past month. Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
See More
Previous Close:
$53.40
Open:
$53.43
24h Volume:
1.04M
Relative Volume:
1.58
Market Cap:
$2.54B
Revenue:
-
Net Income/Loss:
$-146.66M
P/E Ratio:
-20.02
EPS:
-2.7541
Net Cash Flow:
$-133.21M
1W Performance:
+5.11%
1M Performance:
+46.56%
6M Performance:
+66.57%
1Y Performance:
-1.92%
1-Day Range:
Value
$52.77
$55.58
1-Week Range:
Value
$51.51
$56.84
52-Week Range:
Value
$26.20
$63.50

Apogee Therapeutics Inc Stock (APGE) Company Profile

Name
Name
Apogee Therapeutics Inc
Name
Phone
650-394-5230
Name
Address
221 CRESCENT ST., WALTHAM
Name
Employee
196
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
APGE's Discussions on Twitter

Compare APGE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
APGE
Apogee Therapeutics Inc
55.15 3.61B 0 -146.66M -133.21M -2.7541
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-25-25 Initiated RBC Capital Mkts Outperform
Jul-07-25 Reiterated BTIG Research Buy
Mar-13-25 Initiated Citigroup Buy
Nov-25-24 Initiated Canaccord Genuity Buy
May-10-24 Initiated BofA Securities Buy
Dec-20-23 Initiated BTIG Research Buy
Aug-08-23 Initiated Guggenheim Buy
Aug-08-23 Initiated Jefferies Buy
Aug-08-23 Initiated Stifel Buy
Aug-08-23 Initiated TD Cowen Outperform
Aug-08-23 Initiated Wedbush Outperform
View All

Apogee Therapeutics Inc Stock (APGE) Latest News

pulisher
06:59 AM

Real time scanner hits for Apogee Therapeutics Inc. explainedQuarterly Profit Review & AI Powered Market Trend Analysis - newser.com

06:59 AM
pulisher
02:59 AM

Is it time to cut losses on Apogee Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - newser.com

02:59 AM
pulisher
Oct 18, 2025

Can Apogee Therapeutics Inc. stock maintain operating marginsTake Profit & Free Safe Entry Trade Signal Reports - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025
pulisher
Oct 18, 2025

Using data filters to optimize entry into Apogee Therapeutics Inc.Trade Risk Summary & Daily Technical Forecast Reports - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

How Apogee Therapeutics Inc. stock reacts to global recession fears2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

BTIG Maintains a Buy on Apogee Therapeutics (APGE) - Insider Monkey

Oct 17, 2025
pulisher
Oct 17, 2025

Will Apogee Therapeutics Inc. stock split attract more investors2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

9 Best Healthcare Stocks with the Highest Upside - Insider Monkey

Oct 17, 2025
pulisher
Oct 16, 2025

How moving averages guide Apogee Therapeutics Inc. trading2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today - MSN

Oct 15, 2025
pulisher
Oct 14, 2025

What indicators show strength in Apogee Therapeutics Inc.July 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsRate Hike & Low Drawdown Investment Strategies - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect? - sharewise.com

Oct 14, 2025
pulisher
Oct 13, 2025

Best Biotech Stocks To ConsiderOctober 9th - MarketBeat

Oct 13, 2025
pulisher
Oct 12, 2025

Technical signs of recovery in Apogee Therapeutics Inc.Trade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics (NASDAQ:APGE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics closes $345 million public offering By Investing.com - Investing.com Nigeria

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics, Inc. Announces Closing of Public - GlobeNewswire

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics closes $345 million public offering - Investing.com

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics Raises $345 Million From Public Offering - MarketScreener

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics Closes $345 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative

Oct 10, 2025
pulisher
Oct 10, 2025

$345M Raised — Apogee Therapeutics Closes Offering of 8.05M Shares Including Pre-Funded Warrants - Stock Titan

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics (NASDAQ:APGE) Given "Buy" Rating at BTIG Research - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

What’s the recovery path for long term holders of Apogee Therapeutics Inc.Swing Trade & Weekly High Conviction Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Does Apogee Therapeutics' (APGE) $300 Million Raise Mark a Shift in Its R&D Ambition? - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics (APGE): Assessing Valuation Following $300 Million Equity Raise - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics: Accelerated Timelines (Again), More Money In The Bank (NASDAQ:APGE) - Seeking Alpha

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics raises $323.3 million in public offering on Nasdaq By Investing.com - Investing.com Nigeria

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics raises $323.3 million in public offering on Nasdaq - Investing.com India

Oct 10, 2025
pulisher
Oct 10, 2025

Apogee Therapeutics Raises $323.3 Million in Offering - TipRanks

Oct 10, 2025

Apogee Therapeutics Inc Stock (APGE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Apogee Therapeutics Inc Stock (APGE) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Dambkowski Carl
Chief Medical Officer
Oct 01 '25
Sale
39.80
5,110
203,378
284,733
Dambkowski Carl
Chief Medical Officer
Sep 03 '25
Sale
37.87
2,725
103,198
233,548
Dambkowski Carl
Chief Medical Officer
Aug 06 '25
Sale
37.78
2,725
102,950
236,273
Dambkowski Carl
Chief Medical Officer
Jul 02 '25
Option Exercise
22.86
7,365
168,364
249,088
Dambkowski Carl
Chief Medical Officer
Jul 02 '25
Sale
45.09
10,090
454,954
238,998
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Cap:     |  Volume (24h):